Konica Minolta Migrates to Precision Medicine

prwhite

Administrator
Staff member
Konica Minolta, Inc. & Innovation Network Corporation of Japan (INCJ) have closed a joint acquisition of Ambry Genetics Corporation—a pioneer & leader in genetic testing. Ambry is the first laboratory in the world to offer hereditary cancer panels and clinical exome sequencing.

According to Shoei Yamana, President and CEO of Konica Minolta, “This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine”.

Ambry & KM see the future of medicine as patient-focused. They partnered to accelerate the development of new diagnostic tests for many different diseases & more precise treatments for patients worldwide. Together—with their combined resources, technology & scale—they plan to advance biomedical research, globally.
 
They see the future of medicine as patent focused, is a very nice and innovative ideas in healthcare industry. By this small print entrepreneur will also get inspiration to get into the healthcare industry
 
Last edited:

PressWise

A 30-day Fix for Managed Chaos

As any print professional knows, printing can be managed chaos. Software that solves multiple problems and provides measurable and monetizable value has a direct impact on the bottom-line.

“We reduced order entry costs by about 40%.” Significant savings in a shop that turns about 500 jobs a month.


Learn how…….

   
Back
Top